Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DR-0201 by Dren Bio for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
DR-0201 is under clinical development by Dren Bio and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...
Data Insights
DR-0201 by Dren Bio for Hematological Tumor: Likelihood of Approval
DR-0201 is under clinical development by Dren Bio and currently in Phase I for Hematological Tumor. According to GlobalData, Phase...